SCHEMBL18153522

SCHEMBL18153522

CCOC(=O)C(C#N)(CC(=O)c1cccs1)c1ccccc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 3/20 0.48
ALDH1A1 P00352 7/20 0.45
HPGD P15428 3/20 0.45
NFKB1 P19838 3/20 0.45
NFKB2 Q00653 3/20 0.45
RELA Q04206 3/20 0.45
RAB9A P51151 6/20 0.42
LMNA P02545 4/20 0.42
NPC1 O15118 4/20 0.42
TSHR P16473 1/20 0.42
CCR1 P32246 1/20 0.42
KMT2A Q03164 4/20 0.41
MEN1 O00255 3/20 0.41
MAPT P10636 2/20 0.41
NPSR1 Q6W5P4 2/20 0.41
KDM4E B2RXH2 2/20 0.40
MAPK1 P28482 2/20 0.40
TP53 P04637 1/20 0.40
CTNNB1 P35222 1/20 0.40
WNT3A P56704 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9734283 0.80 CCR1 (0.47) SMN1; SMN2ALDH1A1TSHRCCR1KMT2A
SCHEMBL9214363 0.78 CCR1 (0.50) SMN1; SMN2ALDH1A1NFKB1RAB9ALMNA
SCHEMBL1625711 0.77 CCR1 (0.48) ALDH1A1TSHRCCR1KMT2AMEN1
SCHEMBL27450756 0.76 CCR1 (0.48) SMN1; SMN2ALDH1A1TSHRCCR1KMT2A
SCHEMBL22323105 0.74 CCR1 (0.54) SMN1; SMN2ALDH1A1NFKB1RAB9ALMNA
SCHEMBL22323061 0.73 CCR1 (0.46) SMN1; SMN2ALDH1A1CCR1KMT2AMEN1
SCHEMBL1626064 0.72 CCR1 (0.44) SMN1; SMN2ALDH1A1HPGDLMNATSHR
SCHEMBL1533281 0.72 CCR1 (0.58) SMN1; SMN2ALDH1A1CCR1KMT2AMEN1
SCHEMBL9734250 0.71 CCR1 (0.54) SMN1; SMN2ALDH1A1CCR1POLB
SCHEMBL6283925 0.71 PIN1 (0.50) SMN1; SMN2ALDH1A1TSHRCCR1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250304597-A1 COMPOSITIONS AND METHODS OF MODULATING SHORT-CHAIN DEHYDROGENASE ACTIVITY BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM 2025-10-02 US disclosed
US-20250243217-A1 COMPOSITIONS AND METHODS OF MODULATING SHORT-CHAIN DEHYDROGENASE ACTIVITY BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM 2025-07-31 US disclosed
US-20240174688-A1 COMPOSITIONS AND METHODS OF MODULATING SHORT-CHAIN DEHYDROGENASE ACTIVITY BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM 2024-05-30 US disclosed
US-20240043440-A1 COMPOSITIONS AND METHODS OF MODULATING SHORT-CHAIN DEHYDROGENASE ACTIVITY BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM 2024-02-08 US disclosed
US-20210317132-A1 COMPOSITIONS AND METHODS OF MODULATING SHORT-CHAIN DEHYDROGENASE ACTIVITY NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2021-10-14 US disclosed
US-20210094968-A1 COMPOSITIONS AND METHODS OF MODULATING SHORT-CHAIN DEHYDROGENASE ACTIVITY BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM 2021-04-01 US disclosed
CN-111132982-A Compositions and methods for modulating short-chain dehydrogenase activity 卡斯西部储备大学 2020-05-08 CN disclosed
EP-3630773-A1 COMPOSITIONS AND METHODS OF MODULATING SHORT-CHAIN DEHYDROGENASE ACTIVITY Case Western Reserve University (US) 2020-04-08 EP disclosed
WO-2018218251-A1 COMPOSITIONS AND METHODS OF MODULATING SHORT-CHAIN DEHYDROGENASE ACTIVITY CASE WESTERN RESERVE UNIVERSITY (US) 2018-11-29 WO disclosed
US-20180118756-A1 COMPOSITIONS AND METHODS OF MODULATING SHORT-CHAIN DEHYDROGENASE ACTIVITY NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2018-05-03 US disclosed
EP-3283074-A1 COMPOSITIONS AND METHODS OF MODULATING SHORT-CHAIN DEHYDROGENASE ACTIVITY Case Western Reserve University (US) 2018-02-21 EP disclosed
WO-2016168472-A1 COMPOSITIONS AND METHODS OF MODULATING SHORT-CHAIN DEHYDROGENASE ACTIVITY CASE WESTERN RESERVE UNIVERSITY (US) 2016-10-20 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250304597-A1 COMPOSITIONS AND METHODS OF MODULATING SHORT-CHAIN DEHYDROGENASE ACTIVITY HPGD, GCDH, HPGDS SMN1; SMN2 2443/4885ALDH1A1 126/4885HPGD 1/4885
US-20210317132-A1 COMPOSITIONS AND METHODS OF MODULATING SHORT-CHAIN DEHYDROGENASE ACTIVITY HPGD, GCDH, HPGDS SMN1; SMN2 2443/4885ALDH1A1 126/4885HPGD 1/4885
US-20240043440-A1 COMPOSITIONS AND METHODS OF MODULATING SHORT-CHAIN DEHYDROGENASE ACTIVITY HPGD, GCDH, HPGDS SMN1; SMN2 2443/4885ALDH1A1 126/4885HPGD 1/4885
US-20240174688-A1 COMPOSITIONS AND METHODS OF MODULATING SHORT-CHAIN DEHYDROGENASE ACTIVITY HPGD, GCDH, HPGDS SMN1; SMN2 2443/4885ALDH1A1 126/4885HPGD 1/4885
US-20210094968-A1 COMPOSITIONS AND METHODS OF MODULATING SHORT-CHAIN DEHYDROGENASE ACTIVITY HPGD, GCDH, HPGDS SMN1; SMN2 2443/4885ALDH1A1 126/4885HPGD 1/4885
US-20250243217-A1 COMPOSITIONS AND METHODS OF MODULATING SHORT-CHAIN DEHYDROGENASE ACTIVITY HPGD, GCDH, HPGDS SMN1; SMN2 2443/4885ALDH1A1 126/4885HPGD 1/4885
US-20180118756-A1 COMPOSITIONS AND METHODS OF MODULATING SHORT-CHAIN DEHYDROGENASE ACTIVITY HPGD, GCDH, HPGDS SMN1; SMN2 2443/4885ALDH1A1 126/4885HPGD 1/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.